Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406373![]() (2-((3,4-trans)-4-Hydroxy-3-(pyridin-2-ylmethyl)chr...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406402![]() (2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 75 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406381![]() (US10336733, Example 25) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406384![]() (2-(Rac-trans)-4-Hydroxy-3-((1-methyl-1H-pyrazol-5-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 360 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406398![]() (US10336733, Example 42) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 35 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406399![]() (US10336733, Example 43) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406405![]() (US10336733, Example 49) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 154 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406361![]() (N-(Cyclopropylsulfonyl)-2-((3R,4S or 3S,4R)-4-hydr...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.17E+3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406365![]() (4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406371![]() (N-(Cyclopropylsulfonyl)-4-fluoro-2-((3R,4S or 3S,4...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 480 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406376![]() (2-((3,4-trans)-4-Hydroxy-3-(pyridin-2-ylmethyl)chr...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 44 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406385![]() (2-((Rac-trans)-4-Hydroxy-3-((5-methyl-1,3,4-thiadi...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 740 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406391![]() (N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 95 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406396![]() (2-((Rac-trans)-3-([1,1′-Biphenyl]-4-ylmethyl...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406396![]() (2-((Rac-trans)-3-([1,1′-Biphenyl]-4-ylmethyl...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406364![]() (2-((3S,4R or 3R,4S)-4-Hydroxy-3-(pyridin-2-ylmethy...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406369![]() (N-(tert-Butylsulfonyl)-4-fluoro-2-((3R,4S or 3S,4R...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 441 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406372![]() (N-(Cyclopropylsulfonyl)-4-fluoro-2-((3S,4R or 3R,4...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406374![]() (N-((Cyclopropylmethyl)sulfonyl)-2-((3,4-trans)-4-h...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406379![]() (2-((3R,4S or 3S,4R)-3-Benzyl-4-hydroxychroman-7-yl...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.82E+3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406389![]() (N-(tert-Butylsulfonyl)-2-((3R,4S or 3S,4R)-4-hydro...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 808 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406394![]() (N-(tert-Butylsulfonyl)-2-((3R,4S or 3S,4R)-3-((1-e...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.16E+3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406400![]() (US10336733, Example 44) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 60 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406357![]() (4-Fluoro-2-((3R,4S or 3S,4R)-4-hydroxy-3-(pyridin-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 650 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406358![]() (4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406359![]() (4-Fluoro-2-((3R,4S or 3S,4R)-4-hydroxy-3-(pyridin-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.72E+3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406360![]() (4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 93 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406380![]() (2-((3S,4R or 3R,4S)-3-Benzyl-4-hydroxychroman-7-yl...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406386![]() (2-((Rac-trans)-3-((1-ethyl-1H-pyrazol-5-yl)methyl)...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 538 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406392![]() (N-(tert-Butylsulfonyl)-2-((rac-trans)-3-((1-ethyl-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 81 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406392![]() (N-(tert-Butylsulfonyl)-2-((rac-trans)-3-((1-ethyl-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 36 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406401![]() (US10336733, Example 45) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406402![]() (2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406406![]() (US10336733, Example 50) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 67 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406382![]() (US10336733, Example 26) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 770 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406388![]() (N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406363![]() (2-((3R,4S or 3S,4R)-4-Hydroxy-3-(pyridin-2-ylmethy...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406366![]() (4-Fluoro-2-((3R,4S or 3S,4R)-4-hydroxy-3-(pyridin-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 870 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406367![]() (N-(tert-Butylsulfonyl)-2-((3R,4S or 3S,4R)-4-hydro...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 144 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406383![]() (US10336733, Example 27) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406368![]() (N-(tert-Butylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydro...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406370![]() (N-(tert-Butylsulfonyl)-4-fluoro-2-((3S,4R or 3R,4S...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406378![]() (2-((3S,4R or 3R,4S)-3-Benzyl-4-hydroxychroman-7-yl...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406387![]() (N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 556 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406388![]() (N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406395![]() (2-((Rac-cis)-3-([1,1′-Biphenyl]-4-ylmethyl)-...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 37 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406404![]() (N-(tert-Butylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydro...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406362![]() (N-(Cyclopropylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydr...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 28 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406375![]() (N-(Cyclopentylsulfonyl)-2-((3,4-trans)-4-hydroxy-3...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leukotriene B4 receptor (Homo sapiens (Human)) | BDBM406377![]() (2-((3R,4S or 3S,4R)-3-Benzyl-4-hydroxychroman-7-yl...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.04E+3 | n/a | n/a | n/a | n/a |
Merk Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP... | US Patent US10336733 (2019) BindingDB Entry DOI: 10.7270/Q2RX9FFC | |||||||||||
More data for this Ligand-Target Pair |